Month: 2026-04

NEW YORK, Apr 24, 2026 - (ACN Newswire via SeaPRwire.com) - FastX today announces the official launch of its platform, a next-generation exchange built for professional and active traders who require institutional‑grade tools without surrendering custody or control of their assets. FastX goes live globally on 5 May, with traders able to access the platform directly at fastx.co.FastX combines deep on‑chain liquidity, multi‑asset perpetual futures markets, and an advanced copy-trading engine designed to bridge the gap between traditional finance and the decentralized digital asset ecosystem. By leveraging blockchain technology, the platform delivers low‑latency mirroring of trades across major decentralized networks worldwide—while keeping users in full control of their own wallets and risk."FastX was created by traders for traders," said Adelene, Chief Executive Officer of FastX. "We've spent our careers on Wall Street desks and in crypto markets, and we've seen the same problems repeat: opaque execution, misaligned incentives, and copytrading systems that ask users to blindly outsource decisions. FastX is our answer—a decentralised, transparent infrastructure layer where traders keep custody, and technology works to augment, not replace, their edge."Backed by a team of veteran traders with more than 50 years of combined experience across top Wall Street institutions and leading crypto trading firms, FastX is built from the ground up as a decentralised protocol. Users connect their own wallets, maintain self‑custody at all times, and interact with smart contracts that execute trades on‑chain, rather than relying on a centralised broker or custodial exchange.At launch, FastX will offer:Deep, on‑chain liquidity across a wide range of perpetual markets, designed to support serious position sizes with tight spreads and minimal slippage.A fast, intuitive trading interface accessible directly via fastx.co, allowing traders to plug in with their preferred wallet and start trading in minutes.A transparent affiliate and points system that shares a meaningful portion of platform fees with the community and rewards traders and partners who help grow liquidity and volume.The flagship feature of FastX is its next‑generation copytrading system. Unlike traditional social trading products that mirror orders on a single venue with unpredictable delays, FastX's engine is designed to route and synchronise copy trades across major decentralised exchanges, layering those capabilities on top of FastX's own liquidity.The result is a copytrading experience that aims to:Minimise latency between lead and follower execution.Mitigate structural risks such as slippage, desync, and obvious forms of manipulation.Exploit decentralised advantages, such as transparent on‑chain track records and programmable risk controls, without turning the platform into a centralised black box."Copytrading has always been typecast as a blind, autonomous disaster waiting to happen," Adelene added. "FastX takes the opposite stance. We use technology to bring more transparency, not less—on‑chain track records, built‑in risk parameters, and infrastructure that reduces front‑running and execution games wherever possible. Over time, our goal is to layer AI‑driven intelligence on top of this foundation so that users can benefit from advanced analytics and risk management, rather than just 'follow and hope'."FastX is currently seed‑funded by a network of angels deeply embedded in the global crypto trading ecosystem. These backers share a common view that the next generation of markets will be built on open, verifiable rails and that traders deserve better, more transparent instrumentation for expressing and managing risk. FastX is assembling a strong advisory board of experienced traders, market makers, and technologists to guide the exchange through its next phase of growth.As a decentralised protocol, FastX does not take custody of user funds and does not operate as a traditional broker. All positions, liquidations, and fee flows are visible on‑chain, giving traders clear, verifiable insight into how the system behaves under all market conditions."Our vision is simple," said Adelene. "We want professional‑grade perpetuals and intelligent copytrading to live where they belong: on transparent, decentralised infrastructure, not in a black box. Launching FastX on 5 May is the first step. From here, we'll continue to ship faster execution, smarter tooling, and AI‑enhanced copytrading that helps traders survive and thrive in 24/7 markets."Traders can learn more and access the exchange at https://fastx.co.About FastXFastX focuses on building decentralised financial infrastructure and tools for professional traders and sophisticated market participants. The company backs products that prioritise self‑custody, transparency, and robust risk management in rapidly evolving digital asset markets.Media ContactBrand: FastX Perpetuals ExchangeContact: Ella HuangWebsite: https://fastx.co/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SHENZHEN, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - China Medical System Holdings Limited (the “Group” or “CMS”) is pleased to announce that the New Drug Application (NDA) in China for the Seasonal Allergic Rhinitis (SAR) indication of MG-K10 (generic name: Comekibart Injection, “MG-K10” or the “Product”), a Class 1 innovative drug anti-IL-4Rα humanized monoclonal antibody injection, for which the Group holds co-development rights (excluding the indication of atopic dermatitis (AD)) and exclusive commercialization rights, was accepted by the National Medical Products Administration of China (NMPA) on 23 April 2026. The Product is proposed for the treatment of adult patients with moderate-to-severe seasonal allergic rhinitis whose symptoms remain inadequately controlled after treatment with intranasal corticosteroids.The acceptance of the NDA represents an important milestone for the Group’s ophthalmology business, CMS Vision, as it expands its therapeutic focus from ophthalmology into the field of otolaryngology (ENT). It also marks another significant milestone in the Group’s research and development progress in the field of type 2 inflammatory diseases. If the Product is successfully approved for marketing, the Group will leverage its strong academic promotion capabilities and extensive commercialization network to accelerate the commercialization of the Product. It is also expected to further enhance the academic brand influence of CMS Vision in the relevant specialty areas and provide new momentum for the Group’s business growth.BIC Potential: Dosing once every 4 weeks; Phase III study met the primary endpoint with a favorable safety profileMG-K10 is an innovative long-acting anti-IL-4Rα humanized monoclonal antibody that simultaneously blocks the signaling pathways of the key type 2 inflammatory cytokines IL-4 and IL-13, thereby exerting immunomodulatory effects. It is being developed for the treatment of type 2 inflammatory diseases, including seasonal allergic rhinitis, asthma, atopic dermatitis (AD), prurigo nodularis, chronic obstructive pulmonary disease (COPD), chronic spontaneous urticaria (CSU), chronic rhinosinusitis with nasal polyps, and eosinophilic esophagitis. Currently marketed anti-IL-4Rα therapies require administration once every two weeks. MG-K10, with its longer half-life, enabling a once-every-four-weeks dosing regimen. It therefore has the potential to become the first long-acting anti-IL-4Rα monoclonal antibody to be marketed globally, with the potential to be best-in-class. MG-K10 has met the primary endpoint in a multicenter, randomized, double-blind, placebo-controlled Phase III clinical trial in adult patients with moderate-to-severe seasonal allergic rhinitis. The results of the Phase III study demonstrated that the primary endpoint achieved statistical significance, with significantly superior efficacy compared with the placebo group, and a favorable safety profile.Focusing on Unmet Needs: ~250 million patients; 62% of moderate-to-severe patients remain inadequately controlled; long-acting breakthrough brings new treatment opportunitiesAllergic rhinitis is a chronic inflammatory disease of the nasal mucosa mediated by IgE, with type 2 inflammation as the core pathogenic mechanism. It occurs in susceptible individuals upon exposure to environmental allergens such as pollen and dust mites. In recent years, the prevalence of the disease in China has increased from 11.1% to 17.6%, affecting approximately 250 million people[1], among whom 52.2% are patients with persistent moderate-to-severe disease[2]. The disease burden is significant and has become an important public health issue. Current standard treatments, including intranasal corticosteroids and antihistamines, have notable limitations. 62% of patients with moderate-to-severe disease remain inadequately controlled[3]. Long-term use of intranasal corticosteroids may lead to adverse reactions such as epistaxis[4], while antihistamines are often associated with side effects such as drowsiness[5], indicating significant unmet clinical needs. As a biologic therapy targeting IL-4Rα, MG-K10 can block the type 2 inflammatory pathway at its source. Compared with currently approved biologics targeting the same pathway (which require dosing once every two weeks), MG-K10 achieves a differentiated breakthrough in dosing frequency with its long-acting property allowing administration once every four weeks, thereby significantly extending dosing intervals. This may help improve patient treatment adherence and reduce the time and economic burden associated with frequent hospital visits. The Product has the potential to provide a new treatment option for patients with moderate-to-severe disease who respond poorly to conventional therapies, thereby reducing the individual and socio-economic burden associated with the disease.On 24 January 2025, the Group through subsidiaries of the Company entered into a Collaboration Agreement (“Agreement”) with Hunan Mabgeek Biotech Co., LTD and its subsidiary for MG-K10. In accordance with the Agreement and supplementary agreements, the Group has obtained the co-development rights (excluding AD) and exclusive commercialization rights for the Product in Mainland China, Hong Kong Special Administrative Region, Macao Special Administrative Region, Taiwan Region and Singapore; its subsidiary Dermavon Holdings Limited has obtained, through its subsidiary, the co-development rights (excluding AD) and exclusive commercialization rights for the Product in the field of dermatological indications in Mainland China.About CMSCMS is a platform company linking pharmaceutical innovation and commercialization with strong product lifecycle management capability, dedicated to providing competitive products and services to meet unmet medical needs.CMS focuses on the global first-in-class (FIC) and best-in-class (BIC) innovative products, and efficiently promotes the clinical research, development and commercialization of innovative products, enabling the continuous transformation of scientific research into clinical practices to benefit patients.CMS deeply engages in several specialty therapeutic fields, and has developed proven commercialization capabilities, extensive networks and expert resources, resulting in leading academic and market positions for its major marketed products. CMS continues to promote the in-depth development in its advantageous specialty fields, strengthening the competitiveness of the Cardiovascular-Kidney-Metabolic/ gastroenterology/ ophthalmology/ skin health businesses, bringing economies of scale in specialty fields. Among them, the skin health business (Dermavon) has become a leading enterprise in its field, and is proposed to be listed independently on the SEHK. Meanwhile, CMS continuously promotes the operation and development of its integrated R&D, manufacturing and commercialization chain in Southeast Asia and the Middle East, capturing growth opportunities in emerging markets to support the high-quality and sustainable development of the Group.Reference1. Cheng L, Chen J, Fu Q, et al. Chinese Society of Allergy Guidelines for Diagnosis and Treatment of Allergic Rhinitis. Allergy Asthma Immunol Res. 2018;10:300‑353.2. Zheng, Ming et al. “Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China.” Allergy vol. 76,2 (2021): 577-581. doi:10.1111/all.145613. White, P et al. “Symptom control in patients with hay fever in UK general practice: how well are we doing and is there a need for allergen immunotherapy?” Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology vol. 28,3 (1998): 266-70. doi:10.1046/j.1365-2222.1998.00237.x4. Rosenblut, A et al. “Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis.” Allergy vol. 62,9 (2007): 1071-7. doi:10.1111/j.1398-9995.2007.01521.x5. Bernstein, Jonathan A et al. “Allergic Rhinitis: A Review.” JAMA vol. 331,10 (2024): 866-877. doi:10.1001/jama.2024.0530CMS Disclaimer and Forward-Looking StatementsThis press release is not intended to promote any products to you and is not for advertising purposes. This press release does not recommend any drugs, medical devices and/or indications. If you want to know more about the diagnosis and treatment of specific diseases, please follow the opinions or guidance of your doctor or other medical and health professionals. Any treatment-related decisions made by healthcare professionals should be based on the patient’s specific circumstances and in accordance with the drug package insert.This press release which has been prepared by CMS does not constitute any offer or invitation to purchase or subscribe for any securities, and shall not form the basis for or be relied on in connection with any contract or binding commitment whatsoever. This press release has been prepared by CMS based on information and data which it considers reliable, but CMS makes no representation or warranty, express or implied, whatsoever, and no reliance shall be placed on, the truth, accuracy, completeness, fairness and reasonableness of the contents of this press release. Certain matters discussed in this press release may contain statements regarding the Group’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. Any forward-looking statements and projections made by third parties included in this press release are not adopted by the Group and the Company is not responsible for such third-party statements and projections.Media ContactBrand: China Medical System Holdings Ltd.Contact: CMS Investor RelationsEmail: ir@cms.net.cnWebsite: https://web.cms.net.cn/en/home/ Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

HONG KONG, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - The 3rd Smart Lighting Expo and the 17th Hong Kong International Lighting Fair (Spring Edition), organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded today at the Hong Kong Convention and Exhibition Centre. The four-day fairs brought together some 900 exhibitors and attracted some 13,000 buyers from 114 countries and regions for on-site visits and sourcing. Buyer numbers recorded growth, including those from Asian markets such as Malaysia and the Philippines; European markets including France, Germany, the Netherlands, Russia and Türkiye; and North and South American markets, including Brazil, Canada and the US, highlighting Hong Kong’s role as a key global hub for lighting products and technology exchange.Jenny Koo, Deputy Executive Director of the HKTDC, said: "This year’s two lighting fairs attracted industry-leading enterprises who showcased cutting-edge high-performance, smart lighting and sustainable products and solutions. The events also attracted quality buyers from global markets. This helps companies diversify supply chains, explore new markets, and underscores Hong Kong’s strength as an ‘International Exhibition Capital’ which boosts efficient business platforms. The fairs are the preferred platform for the industry to showcase innovation, connect with global buyer networks and accelerate business development.”Survey findings: Respondents were most optimistic about the India and Australia marketsTo keep abreast of the latest industry developments, the HKTDC conducted an on-site survey during the fairs, interviewing 450 exhibitors and buyers. The findings show that overall confidence among exhibitors and buyers in future business development has shown a general increase.Key market outlook and product trend findings:49.1% of respondents expect overall sales to increase in the next 12 to 24 months, while 47.6% expect sales to remain stable.Respondents consider India (73.4%), Australia (71%), ASEAN countries (70.4%), and Japan (68.1%) to be promising or very promising target sales markets for lighting products over the next two years in terms of growth.In terms of new market development, exhibitor respondents are actively exploring Middle East (31.8%), Europe (29.5%), ASEAN countries (23.9%), Latin America (17.6%) and North America (14.8%).In the smart lighting segment, respondents identified home automation and intelligent lighting control systems (48.2%), energy saving lighting control solutions (38.2%), and outdoor smart security lighting systems (31.1%) as having the greatest growth potential over the next two years.Compared with conventional lighting products, respondents indicated that consumers are willing to pay an average premium of 29% for lighting products equipped with smart functions.Scenario-based displays and new zones enhance sourcing effectiveness, with positive trade outcomesThe newly launched “Light Lab” features various scenario-based and immersive designs, integrating lighting products into landscape, sports, cultural and artistic application settings. Shanghai Sansi Electronic Engineering showcased plant clamp lights and compact downlights suitable for museum applications. Guoli Zhu, Deputy Chief Engineer of the company said: “The Light Lab has effectively enhanced the presentation of our products, enabling buyers to more intuitively and swiftly grasp product features and their real-world application scenarios. This has successfully attracted buyers from Argentina, Canada, Germany, India, Japan and the US to visit our booth for in-depth discussions. We expect this to result in orders worth over US$1 million.”The Smart Lighting Expo also debuted the “Smart Display and Stage Lighting & Sound Zone” which displayed a wide range of intelligent display solutions. Industry leader Absen participated in the fair for the first time. Benjamin Tang, Senior Sales Engineer, said: “The new zone has effectively enhanced product visibility, attracting buyers from Eastern Europe, Oceania, North America, South America, and South Asia to our booth. These inquiries came from new clients across key sectors such as cultural tourism and stage engineering. We have also successfully engaged in several promising collaboration discussions with potential clients from the Dominican Republic, Hong Kong and Thailand, further strengthening the company’s market expansion plan. We estimate the value of orders from the expo will amount to US$930,000. Riding on this momentum, we have decided to join the Hong Kong International Lighting Fair (Autumn Edition) this year.”The newly launched “Leisure Lighting Zone” has injected new momentum into the Spring Lighting Fair. Rebecca Seo, CFO of NIZ, a first-time exhibitor from Korea, said: “The fair has provided us with an excellent platform to connect with international buyers. We have successfully connected with buyers from Denmark, Germany, Japan, and the US, and a well-known Japanese homeware retailer has already placed an on-site order. Thanks to the strong traffic generated by the new zone, we expect the fair to bring up to US$70 million in orders for our company this year."Supported by Zhongshan as the Special Partner City, the fairs featured the Zhongshan Guzhen Pavilion and Zhongshan Henglan Pavilion under the Zhongshan Smart Home Zone, presenting the manufacturing strength and competitiveness of the region’s lighting industry while supporting enterprises in “going global”. Merry Liu, Manager of Bairan Lighting, an industrial enterprise above designated size in Henglan, Zhongshan, said: “The two lighting fairs provide Zhongshan enterprises with an efficient ‘go-global’ gateway, enabling us to connect directly with buyers from Europe, the Middle East, South America, and Southeast Asia. This helps drive our products and brand onto the international stage. We expect to achieve US$2 million in sales.”During the fair, the HKTDC organised a buying mission to Zhongshan for the first time, visiting several lighting factories and participating in business matching meetings. This initiative aimed to deepen exchange and cooperation within the Zhongshan lighting supply chain. The visit successfully facilitated several substantive business collaborations; New Zealand buyer Spark100 Ltd established a connection with a Zhongshan lighting supplier, with a potential order value estimated between US$100,000 and US$300,000.This year’s exhibition also attracted buyers from the Middle East. Patrick Zhang, VP of sales of Tecnon Lighting Technology from the Shenzhen Pavilion, stated: “At this year’s fair, a buyer from the United Arab Emirates and a US buyer from a leading women’s fashion brand are likely to become our cooperation partners. We expect to generate US$2 million in sales turnover for our company.”As construction projects in the ASEAN region accelerate, market demand for smart lighting solutions continues to expand. Sambath HK, Manager of RS Decoration from Cambodia, stated, “I travelled here specifically to source lighting products for 14 new commercial building and luxury residential projects. I have already met with over 20 new suppliers and identified two potential partners offering smart street lights, solar lights, and decorative lighting products. I will initially purchase US$100,000 worth of smart street lights.”Driven by the Belt and Road Initiative, urban development in participating countries and regions are in full swing, fuelling a continuous surge in demand for high-efficiency and smart lighting products. Aigerim Beisekina, Supply Manager of Karelz.kz from Kazakhstan, said: “This is our first time visiting the twin lighting fairs, to find reliable suppliers for a solar-powered stadium and sports lighting for three international schools currently under construction in Kazakhstan. Through the Click2Match business matching platform, we have identified three potential suppliers from the Chinese Mainland and plan to purchase lighting equipment valued between US$600,000 and US$900,000.”During the fairs, multiple professional events were held, including the Asian Lighting Conference and the Smart Lighting Solutions Forum. Designers and industry representatives from different regions shared market trends, application cases and technological developments, providing forward-looking market insight for the industry.EXHIBITION+ model sustains post-fair business opportunitiesUnder the hybrid EXHIBITION+ model, the twin lighting fairs combined in-person sourcing with online meetings via the HKTDC’s Click2Match smart business-matching platform and hktdc.com sourcing platform. Click2Match will be available until 30 April to facilitate discussions between exhibitors and buyers around the world.Photo download: https://bit.ly/42m6sqDThe 3rd Smart Lighting Expo and the 17th Hong Kong International Lighting Fair (Spring Edition), organised by the Hong Kong Trade Development Council (HKTDC), successfully concluded today at the Hong Kong Convention and Exhibition Centre, attracted some 13,000 buyers from 114 countries and regions for on-site visits and sourcing.The newly launched “Light Lab” adopted a series of scenario-based and immersive designs, integrating lighting products directly into landscape, sports, cultural and artistic application settings, enabling buyers to better understand product features and practical applications.At the Spring Lighting Fair, the featured “Hall of Aurora” brought together 120 international and premium lighting brands, attracting numerous global buyers.The Shanghai Pudong Intelligent Lighting Association also returned to the Smart Lighting Expo for the third consecutive year, presenting the “Intelligent Ecosystem & IoT Supply Chain Zone”.As for the Spring Lighting Fair, exhibitors include the Xiamen Pavilion, and newly participating Changzhou Zouqu District Pavilion and Zhejiang Pavilion, further broadening industry exchange.The two fairs gathered numerous renowned brands and industry leaders, including Absen (photo), an LED display provider featured at the NBA All-Stars Games, the FIFA Qatar World Cup and Qatar Doha World Expo, and a Guinness World Record holder; and Shanghai Sansi, which supplies over 60% of the display screens in Times Square, New York.During the fairs, the HKTDC arranged various matching activities to connect buyers and exhibitors. The photo shows buyer Powermep from the UAE in discussion with an exhibitor.During the fairs, the HKTDC organised a buying mission to Zhongshan for the first time, visiting several lighting factories and participating in business matching meetings, strengthening exchange and cooperation within the Zhongshan lighting supply chain.The Smart Lighting Solution Forum was held on 21 April. Industry experts shared developments in smart home lighting systems and human-centric lighting for home entertainment as well as discussion of the eco-system of health and connected lighting supply chains.As part of the city’s mega-event economy, the Hong Kong Tourism Board (official exhibition promotion partner) arranged special “Cheung Po Tsai” Victoria Harbour night cruises during the fairs to enhance the business travel experience of convention and exhibition visitors.WebsitesHong Kong International Lighting Fair (Spring Edition): hklightingfairse.hktdc.com/tcSmart Lighting Expo: smartlightingexpo.hktdc.com/tcHKTDC Mediaroom: http://mediaroom.hktdc.com/enMedia enquiriesHKTDC’s Communications & Public Affairs Department:Stanley So Tel: (852) 2584 4049 Email: stanley.hp.so@hktdc.orgNavin Law Tel: (852) 2584 4525 Email: navin.cm.law@hktdc.orgSerena Cheung Tel: (852) 2584 4272 Email: serena.hm.cheung@hktdc.orgAbout HKTDCThe Hong Kong Trade Development Council (HKTDC) celebrates its 60th anniversary this year. The HKTDC is a statutory body established in 1966 to promote, assist and develop Hong Kong's trade. With over 50 offices globally, including 13 in the Chinese Mainland, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus. Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com

SPRINGVILLE, UT, Apr 23, 2026 - (ACN Newswire via SeaPRwire.com) - Sisel International�today announced that it has appointed Pamela Ferry as General Manager of Australia and New Zealand as the company accelerates its expansion and transitions to full market operations across the region.Ferry brings more than 20 years of experience in the global direct selling industry, with a focus on international market expansion, distributor growth, and leadership development, including experience supporting the relaunch of underperforming markets and driving renewed growth. Throughout her career, she has held leadership roles focused on building strong teams, developing field leaders, and fostering long-term organizational success. An experienced presenter, trainer, and events professional, Ferry is recognized for her ability to connect with audiences and translate strategy into practical field execution. Her strengths in relationship building and education position her to play a key role in developing Sisel's distributor network and establishing a strong foundation in the region.The appointment comes at a pivotal stage as Sisel expands into the Australian market, with a focus on building infrastructure, enabling�distributor growth, and introducing its science-driven wellness solutions to new audiences. Ferry will lead efforts to develop market operations, strengthen field support, and drive sustainable growth across Australia and New Zealand."Australia represents an important opportunity for Sisel as we continue our international expansion," said Tom Mower Jr., CEO and Co-Founder of Sisel International. "Pamela brings not only deep industry experience, but a proven ability to develop leaders and build strong distributor networks. Her leadership will be instrumental as we establish a long-term presence in the region."About Sisel International Sisel International is a global health and wellness company dedicated to developing high-quality, science-driven products designed to support healthier living. Co-founded by Tom Mower Sr. and led by CEO Tom Mower Jr., Sisel creates supplements, personal care, home care, and wellness solutions formulated without harmful or unnecessary ingredients. Guided by its founding principles, the company is committed to innovation, safety, and quality while empowering individuals to pursue health, longevity, and personal success worldwide.Media Contact:Sisel InternationalMarketing TeamEmail:�marketing@sisel.netWebsite: www.sisel.netSOURCE: Sisel International Copyright 2026 ACN Newswire via SeaPRwire.com. All rights reserved. www.acnnewswire.com